Logo image of IMNN

IMUNON INC (IMNN) Stock Price, Quote, News and Overview

NASDAQ:IMNN - Nasdaq - US15117N6022 - Common Stock - Currency: USD

7.21  +0.21 (+3%)

After market: 7.1501 -0.06 (-0.83%)

IMNN Quote, Performance and Key Statistics

IMUNON INC

NASDAQ:IMNN (7/28/2025, 4:33:30 PM)

After market: 7.1501 -0.06 (-0.83%)

7.21

+0.21 (+3%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High47.4
52 Week Low5.55
Market Cap153.57M
Shares21.30M
Float19.93M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-13 2025-08-13
IPO10-27 1993-10-27


IMNN short term performance overview.The bars show the price performance of IMNN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

IMNN long term performance overview.The bars show the price performance of IMNN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of IMNN is 7.21 USD. In the past month the price decreased by -35.04%. In the past year, price decreased by -57.46%.

IMUNON INC / IMNN Daily stock chart

IMNN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.36 333.00B
AMGN AMGEN INC 14.51 162.01B
GILD GILEAD SCIENCES INC 14.6 140.60B
VRTX VERTEX PHARMACEUTICALS INC N/A 118.34B
REGN REGENERON PHARMACEUTICALS 12.61 60.32B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 42.35B
ARGX ARGENX SE - ADR 103.69 36.43B
ONC BEONE MEDICINES LTD-ADR 7.52 31.87B
BNTX BIONTECH SE-ADR N/A 27.11B
SMMT SUMMIT THERAPEUTICS INC N/A 20.39B
INSM INSMED INC N/A 19.30B
BIIB BIOGEN INC 8.17 18.94B

About IMNN

Company Profile

IMNN logo image Imunon, Inc. is a clinical stage oncology drug company. The company is headquartered in Lawrenceville, New Jersey and currently employs 25 full-time employees. The firm is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The firm is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Company Info

IMUNON INC

997 Lenox Dr Ste 100

Lawrenceville NEW JERSEY US

Employees: 25

IMNN Company Website

IMNN Investor Relations

Phone: 16098969100

IMUNON INC / IMNN FAQ

What is the stock price of IMUNON INC today?

The current stock price of IMNN is 7.21 USD. The price increased by 3% in the last trading session.


What is the ticker symbol for IMUNON INC stock?

The exchange symbol of IMUNON INC is IMNN and it is listed on the Nasdaq exchange.


On which exchange is IMNN stock listed?

IMNN stock is listed on the Nasdaq exchange.


What is IMUNON INC worth?

IMUNON INC (IMNN) has a market capitalization of 153.57M USD. This makes IMNN a Micro Cap stock.


How many employees does IMUNON INC have?

IMUNON INC (IMNN) currently has 25 employees.


What are the support and resistance levels for IMUNON INC (IMNN) stock?

IMUNON INC (IMNN) has a support level at 6.99. Check the full technical report for a detailed analysis of IMNN support and resistance levels.


Should I buy IMUNON INC (IMNN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IMUNON INC (IMNN) stock pay dividends?

IMNN does not pay a dividend.


When does IMUNON INC (IMNN) report earnings?

IMUNON INC (IMNN) will report earnings on 2025-08-13.


What is the Price/Earnings (PE) ratio of IMUNON INC (IMNN)?

IMUNON INC (IMNN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.48).


What is the Short Interest ratio of IMUNON INC (IMNN) stock?

The outstanding short interest for IMUNON INC (IMNN) is 5.47% of its float. Check the ownership tab for more information on the IMNN short interest.


IMNN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IMNN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IMNN. IMNN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IMNN Financial Highlights

Over the last trailing twelve months IMNN reported a non-GAAP Earnings per Share(EPS) of -1.48. The EPS increased by 26.73% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -259.33%
ROE -3936.99%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%46.15%
Sales Q2Q%N/A
EPS 1Y (TTM)26.73%
Revenue 1Y (TTM)N/A

IMNN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to IMNN. The Buy consensus is the average rating of analysts ratings from 10 analysts.


Ownership
Inst Owners2.35%
Ins Owners1.34%
Short Float %5.47%
Short Ratio0.08
Analysts
Analysts80
Price TargetN/A
EPS Next Y40.93%
Revenue Next YearN/A